# Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine in Bilevel Erector Spinae Plane Block in Breast Surgeries

> **NCT05591417** · NA · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 68 (actual)

## Conditions studied

- Analgesia

## Interventions

- **PROCEDURE:** Bilevel Erector spinae plane block
- **PROCEDURE:** Bilateral Erector spinae plane block with dexamethasone
- **PROCEDURE:** Bilateral Erector spinae plane block with dexmedetomidine
- **DRUG:** Intravenous morphine

## Key facts

- **NCT ID:** NCT05591417
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-27
- **Primary completion:** 2024-09-25
- **Final completion:** 2024-09-30
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05591417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05591417, "Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine in Bilevel Erector Spinae Plane Block in Breast Surgeries". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05591417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*